P.01.16 ADALIMUMAB IS MORE EFFECTIVE THAN AZATHIOPRINE AND MESALAMINE AT PREVENTING POSTOPERATIVE RECURRENCE OF CROHN'S DISEASE – A RANDOMIZED TRIAL

Autor:	V. Savarino, Giorgio Sammito, Pietro Dulbecco, Lorenzo Gemignani, L. Bruzzone, Edoardo Savarino, F. Mazza, Valentina Fazio, Giorgia Bodini, Elisa Giambruno, Lorenzo Assandri
Rok vydání:	2013
Předmět:	medicine.medical_specialty Crohn's disease Hepatology business.industry Gastroenterology Azathioprine medicine.disease law.invention Randomized controlled trial law Internal medicine Adalimumab medicine business medicine.drug
Zdroj:	Digestive and Liver Disease. 45:S94-S95
ISSN:	1590-8658
DOI:	10.1016/s1590-8658(13)60261-3
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::92bef5f2f51cf98caab22c92e10f1f1f https://doi.org/10.1016/s1590-8658(13)60261-3 Zobrazit plný text záznamu Full Text from ScienceDirect